A2Z Smart Technologies Corp.
(NASDAQ: AZ) |
$0.820 |
$40.04M |
-1.50% |
Aadi Bioscience Inc.
(NASDAQ: AADI) |
$1.490 |
$36.59M |
-3.87% |
Abeona Therapeutics Inc.
(NASDAQ: ABEO) |
$5.370 |
$220.79M |
-2.54% |
Abits Group Inc
(NASDAQ: ABTS) |
$0.513 |
$18.24M |
+0.59% |
Able View Global Inc.
(NASDAQ: ABLV) |
$1.180 |
$49.84M |
+4.24% |
abrdn Asia-Pacific Income Fund Inc.
(NYSE American: FAX) |
$2.800 |
$693.55M |
+1.45% |
abrdn Australia Equity Fund Inc.
(NYSE American: IAF) |
$4.495 |
$119.64M |
+0.45% |
abrdn Global Income Fund Inc.
(NYSE American: FCO) |
$5.990 |
$80.48M |
+0.34% |
abrdn National Municipal Income Fund
(NYSE American: VFL) |
$10.620 |
$130.39M |
0% |
ABVC BioPharma Inc.
(NASDAQ: ABVC) |
$0.793 |
$9.57M |
+0.25% |
AC Immune SA
(NASDAQ: ACIU) |
$3.670 |
$364.94M |
+0.82% |
Acasti Pharma Inc.
(NASDAQ: ACST) |
$3.110 |
$28.48M |
-0.32% |
Accelerate Diagnostics Inc.
(NASDAQ: AXDX) |
$1.140 |
$27.15M |
-0.87% |
Accuray Incorporated
(NASDAQ: ARAY) |
$1.910 |
$190.55M |
-3.05% |
Achieve Life Sciences Inc.
(NASDAQ: ACHV) |
$4.940 |
$169.99M |
+2.28% |
Achilles Therapeutics
(NASDAQ: ACHL) |
$0.839 |
$35.82M |
-2.79% |
Aclarion Inc.
(NASDAQ: ACON) |
$0.286 |
$2.40M |
-4.31% |
Aclaris Therapeutics Inc.
(NASDAQ: ACRS) |
$1.345 |
$96.21M |
+1.89% |
Acme United Corporation.
(NYSE American: ACU) |
$35.210 |
$128.53M |
-2.28% |
Acri Capital Acquisition Corporation
(NASDAQ: ACAC) |
$11.360 |
$45.87M |
-0.96% |